AI-Powered brain zaps aim to boost memory in Alzheimer's
NCT ID NCT07208734
First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 34 times
Summary
This study tests a personalized brain stimulation device (tACS) for older adults with mild cognitive impairment or mild Alzheimer's. The device uses AI to tailor the stimulation based on each person's brain scans. About 460 participants will join to see if it safely improves memory and thinking.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Xuanwu Hospital, Capital Medical University, Beijing, Beijing 100053
Beijing, Beijing Municipality, 100053, China
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
transcranial alternating current stimulation (tACS) device
What this could lead to
If it works, this could offer a personalized, non-drug way to ease memory and thinking problems in older adults with Alzheimer's.
What could go wrong
This is an early-stage study testing safety and effectiveness. The approach is complex and may not work for everyone. Results are uncertain.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.